Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 19, 2021

SELL
$72.25 - $168.95 $722 - $1,689
-10 Closed
0 $0
Q4 2020

Jan 13, 2021

BUY
$125.56 - $178.74 $1,255 - $1,787
10 New
10 $2,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Arlington Partners LLC Portfolio

Follow Arlington Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Partners LLC with notifications on news.